StonvexLoading…
StonvexStonvexStonvexCore line items from WK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $258.88M | $247.31M | $884.57M | $645.63M | $421.47M |
Operating Income | Not available | $15.32M | $-42.44M | $-50.30M | $-46.90M |
Net Income | Not available | $19.00M | $-26.17M | $-37.98M | $-19.40M |
EPS (Diluted) | $0.65 | $0.33 | $-0.47 | $-0.68 | $-0.73 |
Total Assets | Not available | $1.43B | $1.49B | $1.41B | $1.35B |
Total Liabilities | Not available | $1.44B | $1.50B | $1.45B | $1.41B |
Cash & Equivalents | Not available | $334.26M | $338.77M | $315.91M | $284.25M |
Free Cash Flow OCF − CapEx | Not available | $25.75M | $138.00M | $87.26M | $41.20M |
Shares Outstanding | Not available | 58.44M | 56.27M | 56.22M | 56.13M |